Mir Hashim
Chief Tech/Sci/R&D Officer en RANI THERAPEUTICS HOLDINGS, INC. .
Fortuna: 4 M $ al 31/03/2024
Perfil
Mir Hashim is currently the Chief Scientific Officer & Director at Rani Therapeutics LLC.
He is also the Vice President-Research & Development at InCube Labs LLC since 2008.
Additionally, Dr. Hashim holds the position of Chief Scientific Officer at Rani Therapeutics Holdings, Inc. since 2021.
Previously, he worked as the Head-Pharmacology at GSK Plc.
Dr. Hashim holds a doctorate degree from Memorial University of Newfoundland, an undergraduate degree from Osmania University, and a graduate degree from the University of Hyderabad.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
Rani Therapeutics LLC
 Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA. 2.55% | 29/07/2021 | 786 392 ( 2.55% ) | 2 M $ | 31/03/2024 |
| 31/03/2024 | 374 119 ( inf% ) | 1 M $ | 31/03/2024 | |
| 31/03/2024 | 148 415 ( 0.57% ) | 461 571 $ | 31/03/2024 | |
| 31/03/2024 | 25 649 ( 0.09% ) | 79 768 $ | 31/03/2024 |
Cargos activos de Mir Hashim
| Empresas | Cargo | Inicio |
|---|---|---|
| RANI THERAPEUTICS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 06/04/2021 |
Rani Therapeutics LLC
Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA. | Chief Tech/Sci/R&D Officer | - |
InCube Labs LLC
 InCube Labs LLC Medical SpecialtiesHealth Technology InCube Labs LLC provides therapeutic services and medical devices. It offers treatment to central nervous system, cardiovascular disease, metabolic diseases, micronutrient deficiency, and gastrointestinal end-stage renal disease cancer. The company was founded on February 22, 2007 and is headquartered in San Jose, CA. | Chief Tech/Sci/R&D Officer | 01/09/2008 |
Antiguos cargos conocidos de Mir Hashim.
| Empresas | Cargo | Fin |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | - |
Formación de Mir Hashim.
| Memorial University of Newfoundland | Doctorate Degree |
| Osmania University | Undergraduate Degree |
| University of Hyderabad | Graduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| GSK PLC | Health Technology |
| Empresas privadas | 3 |
|---|---|
Rani Therapeutics LLC
Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA. | Health Technology |
| Rani Therapeutics Holdings, Inc. | |
InCube Labs LLC
InCube Labs LLC Medical SpecialtiesHealth Technology InCube Labs LLC provides therapeutic services and medical devices. It offers treatment to central nervous system, cardiovascular disease, metabolic diseases, micronutrient deficiency, and gastrointestinal end-stage renal disease cancer. The company was founded on February 22, 2007 and is headquartered in San Jose, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Mir Hashim
